SCOPE: Strategies to Combine PrEP With Prevention Efforts
Status:
Withdrawn
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
This pilot, open-label, prospective study will determine the feasibility of integrating
pre-exposure prophylaxis (PrEP) into existing HIV prevention programs for female sex workers
and if women who are enrolled in those programs will adhere to the daily PrEP regimen of
Truvada®. This study will enroll 500 HIV antibody negative female sex workers in Eldoret and
Nairobi, Kenya.
Phase:
N/A
Details
Lead Sponsor:
FHI 360
Collaborators:
Family Health Options Kenya Gilead Sciences Institute of Tropical Medicine Sex Workers Outreach Programme University of North Carolina, Chapel Hill
Treatments:
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination Tenofovir